Matthias Hermann

4.8k total citations
109 papers, 3.0k citations indexed

About

Matthias Hermann is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthias Hermann has authored 109 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pharmacology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthias Hermann's work include Inflammatory mediators and NSAID effects (15 papers), Veterinary Equine Medical Research (11 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). Matthias Hermann is often cited by papers focused on Inflammatory mediators and NSAID effects (15 papers), Veterinary Equine Medical Research (11 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). Matthias Hermann collaborates with scholars based in Switzerland, Germany and United States. Matthias Hermann's co-authors include Thomas F. Lüscher, Frank Ruschitzka, Andreas J. Flammer, Georg Noll, Steffen Gay, Frank Enseleit, Lukas E. Spieker, Isabella Sudano, Michel Neidhart and R. von Fellenberg and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Hermann

105 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Hermann Switzerland 26 729 567 547 370 344 109 3.0k
Keiji Kuba Japan 29 744 1.0× 649 1.1× 676 1.2× 225 0.6× 1.3k 3.6× 59 5.2k
Francesca Santilli Italy 41 1.5k 2.0× 584 1.0× 682 1.2× 600 1.6× 798 2.3× 131 4.6k
Tomohiro Nakayama Japan 30 880 1.2× 195 0.3× 430 0.8× 406 1.1× 958 2.8× 223 3.6k
John G. Gerber United States 33 342 0.5× 401 0.7× 408 0.7× 221 0.6× 400 1.2× 84 3.9k
Donald A. Wiebe United States 29 398 0.5× 241 0.4× 487 0.9× 289 0.8× 463 1.3× 67 3.8k
Bernd Rosenkranz South Africa 32 184 0.3× 545 1.0× 396 0.7× 229 0.6× 540 1.6× 115 3.3k
Xiang Xie China 25 1.1k 1.5× 160 0.3× 590 1.1× 271 0.7× 831 2.4× 186 4.6k
Kyung‐Sang Yu South Korea 32 252 0.3× 612 1.1× 599 1.1× 215 0.6× 918 2.7× 333 4.5k
Howard R. Knapp United States 30 566 0.8× 715 1.3× 749 1.4× 828 2.2× 761 2.2× 56 3.9k
Yumiko Imai Japan 33 706 1.0× 498 0.9× 869 1.6× 258 0.7× 1.3k 3.7× 64 6.1k

Countries citing papers authored by Matthias Hermann

Since Specialization
Citations

This map shows the geographic impact of Matthias Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Hermann more than expected).

Fields of papers citing papers by Matthias Hermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Hermann. The network helps show where Matthias Hermann may publish in the future.

Co-authorship network of co-authors of Matthias Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Hermann. A scholar is included among the top collaborators of Matthias Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Hermann. Matthias Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bernardo, Artur, et al.. (2023). Predicting physical activity following cardiac rehabilitation: A longitudinal observational study.. Rehabilitation Psychology. 68(3). 338–349. 3 indexed citations
3.
Kneidinger, Nikolaus, Jürgen Behr, Katrin Milger, et al.. (2023). Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition. Frontiers in Cardiovascular Medicine. 10. 1198204–1198204. 2 indexed citations
4.
Jellestad, Lena, Bianca Auschra, Urte Scholz, et al.. (2022). Differential associations of emotional and physical domains of the MacNew Heart with changes in 6-min walking test. Quality of Life Research. 32(2). 615–624. 1 indexed citations
5.
Díaz-Cañestro, Candela, Yustina M. Puspitasari, Luca Liberale, et al.. (2021). MMP-2 knockdown blunts age-dependent carotid stiffness by decreasing elastin degradation and augmenting eNOS activation. Cardiovascular Research. 118(10). 2385–2396. 20 indexed citations
6.
Spielmanns, Marc, et al.. (2021). COVID-19 Outbreak During Inpatient Rehabilitation. American Journal of Physical Medicine & Rehabilitation. 100(3). 203–208. 12 indexed citations
7.
Toggweiler, Stefan, Oliver Borst, Frank Enseleit, et al.. (2011). NT‐proBNP Provides Incremental Prognostic Information in Cardiac Outpatients With and Without Echocardiographic Findings. Clinical Cardiology. 34(3). 183–188. 11 indexed citations
8.
Neumann, C., Jan Menne, Volker Schettler, et al.. (2011). An Erythropoietin Gene Polymorphism in the Hypoxia-Responsive Element at Position 3434 Is Possibly Associated with Hypertension. Kidney & Blood Pressure Research. 35(2). 71–76. 4 indexed citations
9.
Flammer, Andreas J., Isabella Sudano, Mathias Wolfrum, et al.. (2011). Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. European Heart Journal. 33(17). 2172–2180. 98 indexed citations
10.
Chenevard, Rémy, David Hürlimann, Lukas E. Spieker, et al.. (2010). Reconstituted HDL in Acute Coronary Syndromes. Cardiovascular Therapeutics. 30(2). e51–7. 32 indexed citations
11.
Bahri, Shadfar, et al.. (2009). Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis. Clinical Drug Investigation. 29(11). 713–719. 2 indexed citations
12.
Flammer, Andreas J., Bruno Ledergerber, Matthias Hermann, et al.. (2008). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial. Heart. 95(5). 385–390. 37 indexed citations
13.
Flammer, Andreas J., Frank Hermann, Isabella Sudano, et al.. (2007). Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity. Circulation. 116(21). 2376–2382. 171 indexed citations
14.
Hermann, Matthias, Martin P. Bogsrud, Espen Molden, et al.. (2006). Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy. Clinical Pharmacology & Therapeutics. 79(6). 532–539. 115 indexed citations
15.
Hermann, Matthias & Thomas F. Lüscher. (2006). Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors?. Nature Clinical Practice Nephrology. 2(4). 174–175. 1 indexed citations
16.
Weise, Andreas, et al.. (2005). Use of Physcomitrella patens actin 5′ regions for high transgene expression: importance of 5′ introns. Applied Microbiology and Biotechnology. 70(3). 337–345. 43 indexed citations
17.
Heinemann, L, Uwe Krämer, Marc Hein, et al.. (2000). Noninvasive Glucose Measurement by Monitoring of Scattering Coefficient During Oral Glucose Tolerance Tests. Diabetes Technology & Therapeutics. 2(2). 211–220. 21 indexed citations
18.
Pellegrini, Antonio, et al.. (1998). Equinins in equine neutrophils: Quantification in tracheobronchial secretions as an aid in the diagnosis of chronic pulmonary disease. The Veterinary Journal. 155(3). 257–262. 4 indexed citations
19.
Bracher, Verena, et al.. (1991). An investigation of the incidence of chronic obstructive pulmonary disease (COPD) in random populations of Swiss horses. Equine Veterinary Journal. 23(2). 136–141. 62 indexed citations
20.
Grünig, Gabriele, et al.. (1990). Fibrin/fibrinogen in lungs and respiratory secretions of horses with chronic pulmonary disease. American Journal of Veterinary Research. 51(6). 945–949. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiji Kuba Breakdown of academic impact, for papers by Francesca Santilli Breakdown of academic impact, for papers by Tomohiro Nakayama Breakdown of academic impact, for papers by John G. Gerber Breakdown of academic impact, for papers by Donald A. Wiebe Breakdown of academic impact, for papers by Bernd Rosenkranz Breakdown of academic impact, for papers by Xiang Xie Breakdown of academic impact, for papers by Kyung‐Sang Yu Breakdown of academic impact, for papers by Howard R. Knapp Breakdown of academic impact, for papers by Yumiko Imai
Rankless by CCL
2026